Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CVS
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
CVS
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

CVS Price Prediction Next Week

Technical Analysis:

Recent price action shows CVS trading in a range between $62-$65. The stock has formed a potential support level around $62, with resistance at $65.29 from recent highs.

News Impact & Fundamental Analysis:

  • CVS recently beat Q4 earnings expectations, with sales of $97.71 billion exceeding consensus of $97.19 billion
  • The company provided strong 2025 guidance with projected revenue of at least $134 billion
  • A notable insider purchase occurred with Director Michael Mahoney buying 30,000 shares at $66.7 per share, totaling $2M
  • However, CVS faces challenges with reduced employee bonuses due to not meeting 2024 financial goals amid rising Medicare costs

Analyst Sentiment: Multiple analysts have recently raised their price targets:

  • Leerink Partners upgraded to Outperform with $75 target
  • Truist Securities maintains Buy with $76 target
  • Barclays maintains Overweight with $73 target
  • Wells Fargo maintains Overweight with $73 target

Price Prediction for Next Week: Based on technical analysis and recent developments:

  • Bullish Case ($66-67): Strong support at $62 holds, positive analyst sentiment drives momentum
  • Base Case ($63-65): Stock continues consolidation within current range
  • Bearish Case ($60-62): Medicare cost pressures persist, breaking below support

Trading Recommendation: SELL with target price of $62. Despite positive analyst sentiment, near-term headwinds from Medicare costs and bonus cuts suggest downward pressure. Technical indicators show overbought conditions after recent rally.

Technical Analysis:

Recent price action shows CVS trading in a range between $62-$65. The stock has formed a potential support level around $62, with resistance at $65.29 from recent highs.

News Impact & Fundamental Analysis:

  • CVS recently beat Q4 earnings expectations, with sales of $97.71 billion exceeding consensus of $97.19 billion
  • The company provided strong 2025 guidance with projected revenue of at least $134 billion
  • A notable insider purchase occurred with Director Michael Mahoney buying 30,000 shares at $66.7 per share, totaling $2M
  • However, CVS faces challenges with reduced employee bonuses due to not meeting 2024 financial goals amid rising Medicare costs

Analyst Sentiment: Multiple analysts have recently raised their price targets:

  • Leerink Partners upgraded to Outperform with $75 target
  • Truist Securities maintains Buy with $76 target
  • Barclays maintains Overweight with $73 target
  • Wells Fargo maintains Overweight with $73 target

Price Prediction for Next Week: Based on technical analysis and recent developments:

  • Bullish Case ($66-67): Strong support at $62 holds, positive analyst sentiment drives momentum
  • Base Case ($63-65): Stock continues consolidation within current range
  • Bearish Case ($60-62): Medicare cost pressures persist, breaking below support

Trading Recommendation: SELL with target price of $62. Despite positive analyst sentiment, near-term headwinds from Medicare costs and bonus cuts suggest downward pressure. Technical indicators show overbought conditions after recent rally.

CVS Similar Chart Price Prediction

The price of CVS is predicted to go up 2.19%, based on the high correlation periods with POOL. The similarity of these two price pattern on the periods is 98.08%.

stocks logo

CVS

stocks logo

POOL

Up: 2.19%Similarity: 98.08%

CVS Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

CVS Price Forecast($)

Potential Return(%)

2025

55.000

14.510

2026

65.000

15.080

2027

70.000

23.940

2028

75.000

32.790

2029

65.000

15.080

2030

75.000

32.790

What is CVS stock price prediction 2025 ?

CVS stock is predicted to reach $55-$60 by the end of 2025, assuming moderate recovery driven by restructuring efforts and improved operational efficiency under new leadership. The stock's current undervaluation (P/E ~7) and potential strategic shifts, such as divestitures, could unlock shareholder value. However, risks remain due to past performance issues and uncertain execution of turnaround plans.

What is CVS stock price prediction 2026 ?

CVS stock is predicted to reach $65 by 2026, reflecting a moderate recovery from its current price of $56.45. This projection is based on potential operational improvements under new management, cost-cutting measures, and a focus on higher-margin segments. However, regulatory risks and ongoing challenges in its healthcare business may limit upside potential.

What is CVS stock price prediction 2027 ?

CVS stock is predicted to reach approximately $70 by 2027. This projection is based on potential operational improvements under new management, cost-cutting measures, and a focus on higher-margin segments, which could drive earnings recovery. However, regulatory risks and uncertainties around its business restructuring may limit upside potential.

What is CVS stock price prediction 2028 ?

CVS stock is projected to reach approximately $75 by 2028, assuming a moderate recovery driven by operational improvements under new management and potential strategic restructuring. This estimate reflects a compounded annual growth rate of about 6% from its current price of $56.45, supported by its undervalued metrics and turnaround potential. However, risks such as regulatory pressures and execution challenges could impact this trajectory.

What is CVS stock price prediction 2029 ?

CVS stock is projected to reach approximately $65 by 2029, assuming moderate recovery driven by restructuring efforts and improved operational efficiency under new leadership. This estimate factors in a potential valuation uplift from current levels, supported by a forward P/E of 7.5 and expected earnings stabilization. However, risks remain due to regulatory uncertainties and potential business model changes.

What is CVS stock price prediction 2030 ?

CVS stock is predicted to reach approximately $75 by 2030. This projection is based on expected recovery in margins, strategic cost-cutting measures, and potential growth in its healthcare segments. However, risks such as regulatory pressures and operational challenges could impact this target.

CVS Revenue Forecast

CVS EPS Forecast

CVS FAQs

What is bull’s view on CVS?

CVS stock has a bullish outlook with a price target of $60-$80. Analysts highlight strong cash flow, demographic tailwinds, and value-based care as key drivers. Despite challenges, the stock's low valuation and potential turnaround under new management make it attractive.

What is bear's view on CVS?

CVS stock closed at $56.48 on January 31, 2025, down 0.60% during regular trading. Bears argue that CVS faces significant challenges, including declining margins (1.4% profit margin in 2024) and ongoing legal risks, such as opioid-related lawsuits. With a forward P/E of 7.46, the stock may appear undervalued, but uncertainty around its turnaround strategy under new leadership keeps bearish sentiment strong.

What is CVS revenue forecast for next quarter？

The market consensus for CVS's revenue in the upcoming quarter is projected to be approximately $93.102B USD.

What is CVS eps forecast for next quarter？

The market consensus for CVS's eps in the upcoming quarter is projected to be approximately $1.567 USD.

CVS VS S&P500

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the organization.

The firm's entry into provider services has the potential to improve returns for all of CVS' segments if it can help patients more easily and cost-effectively manage chronic conditions through early intervention.

CVS' PBM remains an industry leader due to its intense focus on pharmaceutical cost trends that should continue to attract clients.

Ask Intellectia about CVS

CVS Analyst's Forecast

Stephen Baxter

Wells Fargo

Buy

2025-02-13

Price Target

$68 → $73

Upside

+10.04%

Wells Fargo raised the firm's price target on CVS Health to $73 from $68 and keeps an Overweight rating on the shares. The firm notes Q4 results were better than expected. Guidance for 2025 generally as expected with CVS emphasizing importance of setting targets it was confident it could deliver on. Wells continues to see optionality on faster Aetna margin recovery.
Andrew Mok

Barclays

Buy

2025-02-13

Price Target

$71 → $73

Upside

+10.04%

Michael Cherny

Leerink Partners

Hold → Buy

2025-02-13

Price Target

$55 → $75

Upside

+13.05%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

CNO

CNO Financial Group Inc

$40.86
1.54%
stocks logo

OSCR

Oscar Health Inc

$15.67
0.38%
stocks logo

SPR

Spirit AeroSystems Holdings Inc

$33.96
-0.03%
stocks logo

PYCR

Paycor HCM Inc

$22.15
-0.14%
stocks logo

HGV

Hilton Grand Vacations Inc

$40.51
0.10%
stocks logo

OLN

Olin Corp

$25.79
-3.15%
stocks logo

ICUI

ICU Medical Inc

$154.27
0.29%
stocks logo

SMG

Scotts Miracle-Gro Co

$60.71
0.51%
stocks logo

KOF

Coca-Cola Femsa SAB de CV

$86.59
-1.30%
stocks logo

RYN

Rayonier Inc

$26.15
-0.61%